Clinical Trial Update: Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of Inclisiran in Asian participants with atherosclerotic cardiovascular disease or ASCVD high r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypercholesterolemia

Drugs mentioned

• Inclisiran (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypercholesterolemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING